中文 | English
Return
Total: 20 , 1/2
Show Home Prev Next End page: GO
Author:(Zhenying ZHOU)

1.INFLUENCE OF TUMOR CHEMOTHERAPY ON IL-2R CELL EXPRESS OF PERIPHERAL BLOOD CELLS IN PATIENTS WITH MALIGNANT TUMORS

Zhenying ZHOU ; Xiaoliu WU ; Yueqing ZHU

Cancer Research and Clinic 2000;0(01):-

2.THE INFLUENCE OF SURGICAL OPERATION ON APOPTOSIS LEVEL AND PROLIFERATIVE ACTIVITY IN PERIPHERAL BLOOD MONOCYTES OF PATIENTS WITH MALIGNANT TUMORS

Zhenying ZHOU ; Xiaoliu WU ; Yueqing ZHU ;

Cancer Research and Clinic 2001;0(02):-

3.ASSESSMENT OF VITAMIN A STATUS BY CONJUNCTIVAL IMPRESSION CYTOLOGY

Shimin LI ; Zhenying QI ; Yunzhen ZHOU

Acta Nutrimenta Sinica 1956;0(01):-

4.Relativity study between tumor metastasis and the level of immune competent cells in patients with malignant carcinoma

Shukui WANG ; Zhenying ZHOU ; Xiaoliu WU

Chinese Journal of Immunology 2000;0(11):-

5.Effect of radiotherapy on cellular kinetics of peripheral blood monocytes in patients with malignant tumors

Zhenying ZHOU ; Yueqing ZHU ; Xiaoliu WU

Chinese Journal of Radiation Oncology 1992;0(04):-

7.One case of throat B-cell lymphoma with ipsilateral thyroid papillary carcinoma.

Zhenying CUI ; Bo ZHOU ; Zehai DENG

Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2013;27(21):1220-1221

8.A Comparing Study of Different Anesthetic Methods for Patients during Laparoscopic Hysterectomy

Ying ZHOU ; Hui ZHANG ; Zhengyu ZU ; Zhenying LI

Journal of Medical Research 2006;0(12):-

9.Intrahospital dissemination of carbapenem-resistant Acinetobacter baumannii and analysis of the infected patients' prognosis

Qingtao ZHOU ; Bei HE ; Bei YAO ; Zhenying LIU ; Jie ZHANG

Journal of Peking University(Health Sciences) 2011;43(2):213-221

10.Analysis of Effects of Antimicrobial Drug Application Management in Our Hospital during 2011 to 2013

Cunxia ZHOU ; Huijuan ZHANG ; Guiling SHI ; Zhenying ZHAO

China Pharmacy 2015;(20):2765-2767

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 20 , 1/2 Show Home Prev Next End page: GO